Lee Tatham
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- Advanced Drug Delivery Systems 8
- Advancements in Transdermal Drug Delivery 3
- Drug Solubulity and Delivery Systems 2
-
- SARS-CoV-2 and COVID-19 Research 3
- HIV/AIDS drug development and treatment 3
- SARS-CoV-2 detection and testing 3
- Co-authors
- Steve P. Rannard (15 shared papers)Andrew Owen (16 shared papers)Tom O. McDonald (5 shared papers)Rahul P. Bakshi (1 shared paper)Godfree Mlambo (1 shared paper)Marco Siccardi (3 shared papers)Nancy M. Elbaz (2 shared papers)Theresa A. Shapiro (1 shared paper)
- Journals
- European Journal of Pharmaceutics and Biopharmaceutics (2 papers)Food Hydrocolloids (2 papers)Journal of Materials Chemistry B (1 paper)Chemical Science (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Lee Tatham
14 papers receiving 258 citations
Peers
Comparison fields: 5 of 71
- Pharmaceutical Science 86
- Virology 45
- Biomaterials 49
- Infectious Diseases 59
- Molecular Medicine 12
Countries citing papers authored by Lee Tatham
This map shows the geographic impact of Lee Tatham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Tatham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Tatham more than expected).
Fields of papers citing papers by Lee Tatham
This network shows the impact of papers produced by Lee Tatham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Tatham. The network helps show where Lee Tatham may publish in the future.
Co-authors
The 25 scholars most cited alongside Lee Tatham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 63 | |
| 2 | 2014 | 27 | |
| 3 | 2015 | 24 | |
| 4 | 2020 | 23 | |
| 5 | 2021 | 22 | |
| 6 | 2018 | 21 | |
| 7 | 2018 | 20 | |
| 8 | 2013 | 15 | |
| 9 | 2021 | 14 | |
| 10 | 2023 | 9 | |
| 11 | 2014 | 9 | |
| 12 | 2019 | 5 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2024 | 0 | |
| 16 | 2023 | 0 |
About Lee Tatham
Lee Tatham is a scholar working on Pharmaceutical Science, Infectious Diseases, Molecular Biology, Virology and Emergency Medicine, having authored 16 papers that have together received 259 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (8 papers), HIV Research and Treatment (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Advancements in Transdermal Drug Delivery (3 papers), HIV/AIDS drug development and treatment (3 papers), SARS-CoV-2 detection and testing (3 papers), Drug Solubulity and Delivery Systems (2 papers) and HIV-related health complications and treatments (2 papers). The work is most often cited by research in Pharmaceutical Science (86 citations), Virology (45 citations), Biomaterials (49 citations), Infectious Diseases (59 citations) and Molecular Medicine (12 citations). Lee Tatham has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Steve P. Rannard, Andrew Owen, Tom O. McDonald, Rahul P. Bakshi, Godfree Mlambo, Marco Siccardi, Nancy M. Elbaz, Theresa A. Shapiro, Abhai K. Tripathi and Matthew M. Ippolito. Their work appears in journals such as European Journal of Pharmaceutics and Biopharmaceutics, Food Hydrocolloids, Journal of Materials Chemistry B, Chemical Science and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.